FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma

被引:3
|
作者
Jia, Rong [1 ]
Che, Xiaoxuan [1 ]
Jia, Jun [1 ,2 ]
Guo, Jihua [1 ,3 ]
机构
[1] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Oral & Maxillofacial Reconstruct & R, Key Lab Oral Biomed,Minist Educ,Hubei Key Lab Stom, Wuhan 430072, Peoples R China
[2] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430072, Peoples R China
[3] Wuhan Univ, Sch & Hosp Stomatol, Dept Endodont, Wuhan 430072, Peoples R China
基金
中国国家自然科学基金;
关键词
FOXM1; hnRNP C; alternative splicing; oral squamous cell carcinoma; MESSENGER-RNA; TRANSCRIPTION FACTOR; EXPRESSION; TRANSLATION; PROGRESSION; PROMOTES; CYCLE;
D O I
10.3390/biom13091331
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FOXM1 is an oncogenic transcriptional factor and includes several isoforms generated by alternative splicing. Inclusion of alternative exon 9 produces FOXM1a, a transcriptionally inactive isoform. However, the role of FOXM1a in tumorigenesis remains unknown. In addition, the regulatory mechanisms of exon 9 splicing are also unclear. In the present study, we found that overexpression of FOXM1a significantly reduced cell proliferation and colony formation of oral squamous cell carcinoma (OSCC) cell proliferation in vitro. Importantly, OSCC cells with FOXM1a overexpression showed significantly slower tumor formation in nude mice. Moreover, we identified a U-rich exonic splicing suppressor (ESS) which is responsible for exon 9 skipping. Splicing factor heterogeneous nuclear ribonucleoprotein C (hnRNP C) can bind to the ESS and suppress exon 9 inclusion and FOXM1a expression. Silence of hnRNP C also significantly suppresses OSCC cell proliferation. HnRNP C is significantly co-expressed with FOXM1 in cancers. Our study uncovered a novel regulatory mechanism of oncogene FOXM1 expression in OSCC.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC)
    Wu Yungang
    Li Xiaoyu
    Pang, Taizhong
    Li Wenming
    Pan, Xinliang
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (02) : 149 - 154
  • [2] FoxM1: Repurposing an oncogene as a biomarker
    Nandi, Deeptashree
    Cheema, Pradeep Singh
    Jaiswal, Neha
    Nag, Alo
    SEMINARS IN CANCER BIOLOGY, 2018, 52 : 74 - 84
  • [3] FOXM1 is regulated by DEPDC1 to facilitate development and metastasis of oral squamous cell carcinoma
    Qiu, Jing
    Tang, Yongping
    Liu, Lan
    Yu, Jiangbo
    Chen, Zhenggang
    Chen, Hao
    Yuan, Rongtao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] The role of FOXM1 in senescence suppression and radiation resistance in oral cavity squamous cell carcinoma
    Shrivastava, Nitisha
    Wallach, Yisrael
    Li, Daniel
    Thomas, Carlos
    Prystowsky, Michael B.
    Basu, Indranil
    Guha, Chandan
    Ow, Thomas J.
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Overexpression of FOXM1 as a target for malignant progression of esophageal squamous cell carcinoma
    Song, Liang
    Wang, Xiaohang
    Feng, Zhen
    ONCOLOGY LETTERS, 2018, 15 (04) : 5910 - 5914
  • [6] Clinicopathological and Prognostic Significance of FOXM1 Expression in Esophageal Squamous Cell Carcinoma
    Takata, Akihiro
    Takiguchi, Shuji
    Okada, Kaoru
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Yamasaki, Makoto
    Miyata, Hiroshi
    Nakajima, Kiyokazu
    Mori, Masaki
    Doki, Yuichiro
    ANTICANCER RESEARCH, 2014, 34 (05) : 2427 - 2432
  • [7] Overexpression of FoxM1 in Sinonasal Inverted Papilloma and Associated Squamous Cell Carcinoma
    Wang, Huan
    Li, Han
    Hu, Li
    Wang, Jingjing
    Liu, Quan
    Wang, Dehui
    Sun, Xicai
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2019, 33 (06) : 706 - 715
  • [8] Overexpression of FoxM1 is Associated with Tumor Progression in Patients with Renal Cell Carcinoma
    Xue, Y.
    Zhang, G.
    Xu, R.
    Zou, X.
    Zhong, X.
    Wu, G.
    Wang, X.
    Long, D.
    Wu, Y.
    Xu, H.
    Liu, M.
    UROLOGY, 2012, 80 (03) : S107 - S107
  • [9] Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma
    Yu, Min
    Tang, Zheng
    Meng, Fandi
    Tai, Minghui
    Zhang, Jingyao
    Wang, Ruitao
    Liu, Chang
    Wu, Qifei
    TUMOR BIOLOGY, 2016, 37 (01) : 1289 - 1297
  • [10] Prognostic significance of FOXM1 in oral squamous cell carcinoma patients treated by docetaxel-containing regimens
    Harada, Koji
    Ferdous, Tarannum
    Minami, Haruyasu
    Mishima, Katsuaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (01) : 29 - 36